MedPath

To evaluate the efficacy of leuc capsule in leucorrhoea

Not Applicable
Not yet recruiting
Conditions
Noninflammatory disorder of vagina, unspecified. Ayurveda Condition: YONIROGAH/YONI-VYAPADAH,
Registration Number
CTRI/2023/06/053378
Lead Sponsor
PUNARVASU PHARMACY
Brief Summary

Leucorrhoea or white discharge is a complaint with which each woman suffers at least once in a lifetime. It refers to the white or yellowish discharge from the vaginal canal. The symptoms of swetapradara either physiological or pathological results into great discomfort and deep agony in the individuals1 Leucorrhoea is found significantly more in married females as compared to unmarried, pregnant as compared to non-pregnant, and women of lower socioeconomic status with high parity.2Symptoms of Leucorrhoea are somewhat similar to *Shwetapradara* mentioned in *Ayurvedic* literature but there is no separate chapter given in *Brihatrayee*. Commentator *Chakrapani* has explained the word *Pandura-Asrigdara* as *Shwetapradara* in his commentary.3Taking into account the side effects and adverse effects of contemporary management , The *Ayurvedic* management can be recommended as a safer, feasible and effective therapy for the management of leucorrhea. In this study, *Ayurveda* management by LEUC **CAPSULE** (combination of Extract of *Ashwagandha, Lodhra, Udumber, Guduchi, Vruddhadaru ; Kukutanda twak bhasma, Godanti bhasma, sharkara* ) will be carried out to evaluate the efficacy in leucorrhoea.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
30
Inclusion Criteria

Patients having any complaint of discharge per vagina, Itching sensation at vulva, Burning sensation in vagina, Pain in vagina, Foul smell from vagina , backache and pelvic pain.

Exclusion Criteria
  • Female patients having pregnancy, breast feeding or post-delivery period.
  • Patients with any reproductive tract malignancy.
  • Patients with other systemic illness.
  • Patients with positive history of venereal diseases Patients who are using CU-T or chemical method of contraception.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
white discharge from vagina will reduceat 4 week
Secondary Outcome Measures
NameTimeMethod
no reoccurrence of white discharge6 weeks

Trial Locations

Locations (1)

JS Ayurveda Mahavidyalaya

🇮🇳

Kheda, GUJARAT, India

JS Ayurveda Mahavidyalaya
🇮🇳Kheda, GUJARAT, India
DrVaishali Dave
Principal investigator
09662140078
vaishalivasavda@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.